Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 16.75 +0.50 (+3.08%)
As of 04/17/2025 12:46 PM Eastern

FDBK vs. COG, INHC, TRLS, IQAI, DVRG, SENS, EMIS, CRW, INS, and KOO

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Cambridge Cognition (COG), Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), and Kooth (KOO). These companies are all part of the "health information services" industry.

Feedback vs.

Cambridge Cognition (LON:COG) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

In the previous week, Cambridge Cognition's average media sentiment score of 1.49 beat Feedback's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the media.

Company Overall Sentiment
Cambridge Cognition Positive
Feedback Neutral

35.2% of Cambridge Cognition shares are held by institutional investors. Comparatively, 53.2% of Feedback shares are held by institutional investors. 29.9% of Cambridge Cognition shares are held by insiders. Comparatively, 10.8% of Feedback shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cambridge Cognition has a net margin of -10.07% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Cognition-10.07% -68.83% -0.30%
Feedback -279.16%-39.71%-22.99%

Feedback received 60 more outperform votes than Cambridge Cognition when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%

Cambridge Cognition has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.

Cambridge Cognition has higher revenue and earnings than Feedback. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Cognition£15.64M0.94-£1.58M-£3.76-9.35
Feedback£3.88M1.89-£10.84M-£24.74-0.68

Summary

Cambridge Cognition and Feedback tied by winning 7 of the 14 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£7.34M£193.86M£5.30B£2.50B
Dividend Yield4.56%6.68%5.45%4.91%
P/E Ratio-0.68213.4921.86129.96
Price / Sales1.89466.85380.66233,433.26
Price / Cash1.1247.1438.2628.23
Price / Book0.295.096.454.41
Net Income-£10.84M-£15.55M£3.22B£5.86B
1 Month Performance1.52%-3.57%-9.76%-1.34%
1 Year Performance-84.77%6.00%11.48%41.10%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 16.75
+3.1%
N/A-84.9%£7.34M£3.88M-0.6824High Trading Volume
COG
Cambridge Cognition
N/AGBX 34.10
-3.9%
N/A-33.6%£14.28M£15.64M-9.0680Gap Down
INHC
Induction Healthcare Group
N/AGBX 9.50
flat
N/A-31.9%£8.77M£12.57M-1.7174High Trading Volume
TRLS
Trellus Health
N/AGBX 1.62
-12.4%
N/A+3.4%£3.13M£65,831.01-0.4731Gap Down
IQAI
IQ-AI
N/AGBX 0.77
+1.3%
N/A-47.4%£1.71M£538,190.00-13.676Positive News
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.7284 of 5 stars
GBX 1,580
+1.9%
GBX 2,800
+77.2%
-28.8%£678.87M£230.77M58.37734High Trading Volume
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
2.5719 of 5 stars
GBX 145
-5.2%
GBX 456.67
+214.9%
-43.4%£53.22M£50.72M13.62478Earnings Report
Analyst Forecast
News Coverage

Related Companies and Tools


This page (LON:FDBK) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners